search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
DEP AR TMENT F OR INTERNATIONAL T RADE


commissioning services – enable patients to access all NHS services. These include organisations that provide innovative local primary care delivery in the UK, including AT Medics and Modality, to wider national resilience on public health, including the UK Health Security Agency (UKHSA). Innovation – quick systematic delivery of innovation


is provided through organisations like Accelerated Access Collaborative (AAC), NIHR, NICE and Academic Health Science Networks (AHSNs). New approaches have been developed to emerging challenges such as sustainability, cutting edge infrastructure and pandemic response. Organisations such as the Cell & Gene Therapy Catapult or Congenica in precision medicine; Currie & Brown in smarter infrastructure; Newcastle NHS Foundation Trust in decarbonisation; and NHS South, Central and West or Diamond Light Source in pandemic resilience are all great examples here. The UK’s leadership in genomics is recognised


globally, from the completion of the 100,000 Genome Project and UK Biobank, Genomics England through to the NHS Genomics Medicine


The UK Department for International Trade (DIT) has created an insightful collection of leading UK innovators from the public and private UK healthcare sector who want to work in partnership with healthcare providers and organisations internationally. These can be found here at discoverhss.co.uk/


Service. The Genome UK Strategy sets out an ambition for the UK to be the world’s most advanced genomic healthcare ecosystem. This presents opportunities to accelerate research, develop innovations in new technologies and data science, and to apply genomics in the clinical setting to diagnose disease at an earlier stage and also predict and prevent diseases before they might appear. Innovation in genomic healthcare, informatics tools and precision medicine has been evidenced by the Genomic surveillance of the SARS- CoV-2 virus, by the world-leading Wellcome Sanger Institute.


12 UKHEALTHCARE P A VILION. COM


DUB AI 2023


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58